Kura Oncology, Inc.

We are a clinical-stage biopharmaceutical company founded in 2014, focusing on developing precision medicines for cancer. We create small-molecule drug candidates that target cancer’s signaling pathways and other drivers, with the goal of identifying patients who will benefit most from treatment.

Our pipeline includes three investigational drug candidates: ziftomenib, tipifarnib, and KO-2806. Ziftomenib is an oral drug candidate for genetically defined AML patients, targeting the menin-KMT2A protein-protein interaction. It is currently in a Phase 2 registration trial (KOMET-001) for NPM1-mutant relapsed or refractory AML. We also plan multiple Phase 1 trials to evaluate combinations in earlier lines of therapy and other patient populations. Tipifarnib, an FTI, is in a Phase ¹⁄₂ trial (KURRENT-HN) combined with alpelisib for patients with PIK3CA-dependent HNSCC. KO-2806, a next-generation FTI, will be evaluated in a Phase 1 dose-escalation trial (FIT-001) as a monotherapy and in combination with other targeted therapies for adult patients with advanced solid tumors.

Our mission is to deliver on the promise of precision medicines, helping cancer patients live better, longer lives. We aim to help patients achieve long-lasting remission through targeted, well-tolerated treatments.

Our culture values diverse and talented professionals, all with a patient-focused mindset. We are committed to executing our work with integrity and grit, operating collaboratively and resourcefully.

We have between 51 and 200 employees. Our team works with a patient-focused mindset to advance precision medicines for cancer.

Our culture is collaborative, values-driven, and resourceful, supporting diverse professionals. We emphasize cross-functional collaboration and are committed to executing our goals.

We offer a comprehensive benefits package, including:

• A substantial employer match, equity, and participation in an annual target bonus.
• 401K with employer contributions, generous stock options, and an ESPP Plan.
• 20 days of PTO to start, plus 18 holidays, including Summer and Winter Breaks.
• Paid parental leave.
• In-office catered lunches, a home office setup, and a lifestyle spending stipend.
• A commuter stipend for employees in our Boston office.
• Regular social activities like happy hours, celebrations, and Kura Koffee Talks.
• Opportunities for career advancement and development.